Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             115 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Antidepressant use and salivary cortisol in depressive and anxiety disorders Manthey, Leonie
 2011
 21 Supplement 3 p. 691-699
9 p.
 artikel
2 C.07.02 Beyond acute mood episodes: long-term management and revised concepts in bipolar disorder Leboyer, M.
 2011
 21 Supplement 3 p. S629-
1 p.
 artikel
3 C.11.03 Circadian functioning in affective disorders McClung, C.
 2011
 21 Supplement 3 p. S635-
1 p.
 artikel
4 C.02.03 Early intervention in major depressive disorder Menchón, J.
 2011
 21 Supplement 3 p. S624-
1 p.
 artikel
5 C.01.01 Emerging biological approaches for identifying depression and predicting response to treatment Larsen, J.
 2011
 21 Supplement 3 p. S623-
1 p.
 artikel
6 C.12.02 Evidence-based antidepressant efficacy of agomelatine Demyttenaere, K.
 2011
 21 Supplement 3 p. S636-
1 p.
 artikel
7 Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers Andreou, Dimitrios
 2011
 21 Supplement 3 p. 700-704
5 p.
 artikel
8 ECNP Announcement: Late Registration 2011
 21 Supplement 3 p. II-
1 p.
 artikel
9 Effects of age on dopamine D2 receptor availability in striatal subdivisions: A high-resolution positron emission tomography study Kim, Jong-Hoon
 2011
 21 Supplement 3 p. 885-891
7 p.
 artikel
10 Effects of olanzapine on extracellular concentrations and tissue content of neurotensin in rat brain regions Gruber, Susanne H.M.
 2011
 21 Supplement 3 p. 918-927
10 p.
 artikel
11 Effects of voluntary ethanol consumption on emotional state and stress responsiveness in socially isolated rats Pisu, Maria Giuseppina
 2011
 21 Supplement 3 p. 414-425
12 p.
 artikel
12 Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: Comprehensive review of prospective head-to-head and placebo-controlled comparisons Fraguas, David
 2011
 21 Supplement 3 p. 621-645
25 p.
 artikel
13 E.05.01 Neuroimaging genetics in psychiatry research Meyer-Lindenberg, A.
 2011
 21 Supplement 3 p. S234-
1 p.
 artikel
14 E.01.02 New guidelines Cosyns, P.
 2011
 21 Supplement 3 p. S233-
1 p.
 artikel
15 Erk activation in the amygdala and hippocampus induced by fear conditioning in ethanol withdrawn rats: Modulation by mk-801 Bertotto, María Eugenia
 2011
 21 Supplement 3 p. 892-904
13 p.
 artikel
16 Involvement of the neurotrophin and cannabinoid systems in the mechanisms of action of neurokinin receptor antagonists Hassanzadeh, Parichehr
 2011
 21 Supplement 3 p. 905-917
13 p.
 artikel
17 Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus Schäble, S.
 2011
 21 Supplement 3 p. 484-494
11 p.
 artikel
18 P.3.a.012 Age of onset of schizophrenia and outcomes in 29 placebo-controlled RCT's of antipsychotics in the NEWMEDS repository Rabinowitz, J.
 2011
 21 Supplement 3 p. S459-S460
2 p.
 artikel
19 P.8.a.005 Assessment of cardiovascular disease risk for community psychiatric patients attending a physical health clinic Luft, B.
 2011
 21 Supplement 3 p. S613-S614
2 p.
 artikel
20 P.1.a.004 Association analysis of polymorphisms on neuregulin 3 (nrg3) gene with schizophrenia in the Korean population Woo, S.
 2011
 21 Supplement 3 p. S239-
1 p.
 artikel
21 P.1.a.012 Confirmation of association between genetic markers in 5HTR2A and response to mGLU2/3 agonist LY2140023 monohydrate in schizophrenia Nisenbaum, L.
 2011
 21 Supplement 3 p. S243-S244
2 p.
 artikel
22 P.6.a.012 Effects of transcranial neuromagnetic and neuroelectical stimulation on alcohol craving Notaristefano, A.
 2011
 21 Supplement 3 p. S565-S566
2 p.
 artikel
23 P.1.a.020 GNB 3 825TT genotype: older age at onset in major depressive disorders? Gressier, F.
 2011
 21 Supplement 3 p. S248-
1 p.
 artikel
24 P.1.029 Alterations in somatostatin binding sites in brains of rats subjected to chronic mild stress Kusmider, M.
 2011
 21 Supplement 3 p. S132-
1 p.
 artikel
25 P.1.a.013 PER 3 gene variation is not associated with diurnal preference in a Korean young population Kang, S.G.
 2011
 21 Supplement 3 p. S244-
1 p.
 artikel
26 P.2.a.022 Phase 3 dose selection for PNB01, a novel fixed dose combination antidepressant inducing a faster and sustained response Buntinx, E.
 2011
 21 Supplement 3 p. S366-S367
2 p.
 artikel
27 P.2.a.006 Plasma vascular endothelial growth factor (VEGF) and suicide risk Jokinen, J.
 2011
 21 Supplement 3 p. S357-
1 p.
 artikel
28 P.3.009 A principal component analysis of treatment patterns according to clinical features in a naturalistic cohort study of bipolar patients Nivoli, A.M.A.
 2011
 21 Supplement 3 p. S65-S66
2 p.
 artikel
29 P.7.a.005 Safety and tolerability of lamotrigine treatment in psychiatric and nonpsychiatric adolescent patients: a retrospective cohort study Bhang, S.
 2011
 21 Supplement 3 p. S602-
1 p.
 artikel
30 P.2.007 Assessment of memory and learning of lithium-treated euthymic bipolar patients Suwalska, A.
 2011
 21 Supplement 3 p. S140-
1 p.
 artikel
31 P.2.a.003 Stress coping strategies and HPA axis regulation predict relapse risk in remitted depression Hoehne, N.
 2011
 21 Supplement 3 p. S355-
1 p.
 artikel
32 P.2.a.020 The effects of escitalopram on sleep problems in patients with major depressive disorder or GAD: a comparison with SSRIs and SNRIs Stein, D.
 2011
 21 Supplement 3 p. S365-S366
2 p.
 artikel
33 P.4.a.011 The use of Yale-Brown Obsessive-Compulsive Scale: new views of an old measure Diniz, J.
 2011
 21 Supplement 3 p. S531-S532
2 p.
 artikel
34 P.8.a.001 Treatment adherence of psychiatric patients in an outpatient setting Oosthuizen, F.
 2011
 21 Supplement 3 p. S611-
1 p.
 artikel
35 P.2.b.020 Antidepressant -like effect induced by pharmacological or genetic inhibition of inducible nitric oxide synthase in mice Montezuma, K.
 2011
 21 Supplement 3 p. S379-
1 p.
 artikel
36 P.5.b.004 Cognition and hippocampal plasticity in 5XFAD mouse model of Alzheimer's disease Sonn, K.
 2011
 21 Supplement 3 p. S550-
1 p.
 artikel
37 P.2.b.010 Dysfunctional hippocampal neurotransmission in the rat chronic mild stress model of depression Wiborg, O.
 2011
 21 Supplement 3 p. S373-
1 p.
 artikel
38 P.6.b.011 L -Nitro-arginine methyl ester in the dorsolateral periaqueductal gray matter decreases anxiety-like behaviour during ethanol withdrawal Bonassoli, V.T.
 2011
 21 Supplement 3 p. S573-S574
2 p.
 artikel
39 P.1.b.004 Mismatch negativity in depressed patients under selective noradrenergic and serotonergic antidepressants Norra, C.
 2011
 21 Supplement 3 p. S251-S252
2 p.
 artikel
40 P.6.b.014 NOS 1 gene Ex1f-VNTR polymorphism influences alcohol consumption in humans Laas, K.
 2011
 21 Supplement 3 p. S575-
1 p.
 artikel
41 P.2.b.023 Role of alpha2-adrenoceptor in trazodone modulatory effect of 5-HT cortical levels Garrone, B.
 2011
 21 Supplement 3 p. S380-S381
2 p.
 artikel
42 P.4.b.014 The anxiolytic-like effects of the estrogen receptor beta agonist, WAY-200070, involve activation of AMPA receptors Hughes, Z.A.
 2011
 21 Supplement 3 p. S540-S541
2 p.
 artikel
43 P.2.c.028 An independent meta-analysis on the efficacy of agomelatine versus placebo and versus SSRIs in major depression Ballesteros, J.
 2011
 21 Supplement 3 p. S398-S399
2 p.
 artikel
44 P.3.c.005 Assessment of functional capacity of schizophrenia patients in the Czech and Slovak Republics: a cross-sectional study Mohr, P.
 2011
 21 Supplement 3 p. S470-
1 p.
 artikel
45 P.2.c.025 Efficacy of duloxetine in perimenopausal women with depressive and vasomotor symptoms Zavoianu, M.
 2011
 21 Supplement 3 p. S397-
1 p.
 artikel
46 P.1.c.025 Evaluation of poly(amidehydroxyurethane) coated silver nanoparticles influence on morphine-induced place preference in rats Tartau, L.
 2011
 21 Supplement 3 p. S267-
1 p.
 artikel
47 P.1.c.011 Influence of afobazol on profile change neuromediator amino acids in structures of rats brain in model of global ischemia Baykova, V.
 2011
 21 Supplement 3 p. S259-
1 p.
 artikel
48 P.2.c.011 Is pharmacogenetic testing ready for antidepressant treatment? A costeffectiveness simulation Olgiati, P.
 2011
 21 Supplement 3 p. S389-
1 p.
 artikel
49 P.1.c.001 Mechanisms of antidepressant activity for TC-5214: a selective, centrally-acting neuronal nicotinic channel modulator Quirk, M.
 2011
 21 Supplement 3 p. S253-S254
2 p.
 artikel
50 P.3.c.060 Olanzapine standard and orally-disintegrating tablets: a crossover study of metabolic measures Loza, B.
 2011
 21 Supplement 3 p. S503-
1 p.
 artikel
51 P.4.010 Considerably different mechanisms underlie the effects of the ACTH(4–10) analogue semax on stress-induced analgesia and stress-induced behaviour Manchenko, D.
 2011
 21 Supplement 3 p. S150-
1 p.
 artikel
52 P.3.c.036 Pharmacological management of acutely agitated patients: a double-blind, randomised comparison of four intramuscular interventions Mantovani, C.
 2011
 21 Supplement 3 p. S489-
1 p.
 artikel
53 P.3.c.019 Risk of pathological decrease of bone mineral density in patients on parenteral risperidone long-term treatment Marin, R.
 2011
 21 Supplement 3 p. S478-S479
2 p.
 artikel
54 P.1.c.056 Serum brain-derived neurotrophic factor levels increase with the improvement of neuropsychiatric manifestations in systemic lupus Louzada-Junior, P.
 2011
 21 Supplement 3 p. S285-
1 p.
 artikel
55 P.3.c.002 Structured relaxation in the treatment of akathisia: case series Hansen, L.
 2011
 21 Supplement 3 p. S468-S469
2 p.
 artikel
56 P.1.c.042 The acute effects of morning versus evening dose of hydroxyzine on cognition and on the event related potential Conen, S.
 2011
 21 Supplement 3 p. S277-
1 p.
 artikel
57 P.3.c.063 The evolution of antipsychotic switch and polypharmacy in natural practice: a longitudinal perspective Tsutsumi, C.
 2011
 21 Supplement 3 p. S505-
1 p.
 artikel
58 P.1.c.059 The MDR1 C3435T polymorphism and valproic acid plasmatic level in Romanian epileptic patients Bocsan, I.C.
 2011
 21 Supplement 3 p. S287-
1 p.
 artikel
59 P.3.c.046 Treatment with antipsychotics in hospitalised patients with bipolar disorder Mahia, M.C. Garcia
 2011
 21 Supplement 3 p. S495-
1 p.
 artikel
60 P.6.d.003 Acute administration of full 5-HT1B agonist suppresses methamphetamine intake in IV self-administration rat model Kucerova, J.
 2011
 21 Supplement 3 p. S583-S584
2 p.
 artikel
61 P.1.d.023 Altered brain derived neurotrophic factor signaling and serotonergic neurotransmission in NCAM-deficient mice Aonurm-Helm, A.
 2011
 21 Supplement 3 p. S302-S303
2 p.
 artikel
62 P.5.d.001 1-Benzyl-1,2,3,4-tetrahydroisoquinoline triggered an increase of caspase-3 activity and prevented L-DOPA-induced effects in rat brain Antkiewicz-Michaluk, L.
 2011
 21 Supplement 3 p. S555-
1 p.
 artikel
63 P.2.024 Differential role of the GABA transporters in the regulation of extracellular concentrations of GABA in the rat hippocampus Kersanté, F.
 2011
 21 Supplement 3 p. S53-S54
2 p.
 artikel
64 P.4.d.003 Life-long CRF overproduction is associated with changes in functional sensitivity and gene expression of GABA-A and mGluR receptor subtypes Vinkers, C.H.
 2011
 21 Supplement 3 p. S542-S543
2 p.
 artikel
65 P.2.d.027 Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates Anderson, L.B.
 2011
 21 Supplement 3 p. S417-
1 p.
 artikel
66 P.1.d.009 The rostral ventral medulla contributes to the production of antinociception in pain Abzianidze, E.
 2011
 21 Supplement 3 p. S295-
1 p.
 artikel
67 P.6.d.017 Toluene intoxication causes different effects on the brains of adult and young rats Gelazonia, L.
 2011
 21 Supplement 3 p. S592-
1 p.
 artikel
68 P.2.d.010 Visual hallucinations with sertraline: two case reports Arbell, M.
 2011
 21 Supplement 3 p. S407-
1 p.
 artikel
69 P.6.e.001 Altered brain activity in the anticipatory reward system in young adults with pathological gambling Choi, J.S.
 2011
 21 Supplement 3 p. S593-S594
2 p.
 artikel
70 P.2.e.017 Bipolar subtype and time to an affective event in a cohort of euthymic bipolar disorder outpatients in Spain: a 5 year follow-up study De Dios Perrino, C.
 2011
 21 Supplement 3 p. S427-
1 p.
 artikel
71 P.2.e.014 Effects of magnetic seizure therapy in patients with treatment resistant depression Kayser, S.
 2011
 21 Supplement 3 p. S425-S426
2 p.
 artikel
72 P.5.e.001 Efficacy and safety of galantamine in long-term treatment for mild cognitive impairment Zarra, J.
 2011
 21 Supplement 3 p. S556-S557
2 p.
 artikel
73 P.5.007 Effect of nanosomic erythropoietin in rats with intracerebral post-traumatic haematoma (hemorrhagic stroke) Solev, I.N.
 2011
 21 Supplement 3 p. S157-S158
2 p.
 artikel
74 P.1.e.003 Neuropsychological correlates of brain metabolite measures in chronic schizophrenia Szulc, A.
 2011
 21 Supplement 3 p. S304-S305
2 p.
 artikel
75 P.1.030 Epigenetic modification of the glucocorticoid receptor gene predicts women's salivary cortisol following a threat to the social self Edelman, S.
 2011
 21 Supplement 3 p. S24-S25
2 p.
 artikel
76 P.3.e.016 Self-awareness of cognitive functioning in schizophrenia: patients and their relatives Buonocore, M.
 2011
 21 Supplement 3 p. S521-S522
2 p.
 artikel
77 P.1.e.027 Serotonin -1A receptor binding in the dorsal raphe nucleus is associated with hippocampal grey matter volume Kraus, C.
 2011
 21 Supplement 3 p. S318-S319
2 p.
 artikel
78 P.2.e.027 Supraphysiological doses of levothyroxine in bipolar depression: a randomised controlled, double blind study Stamm, T.
 2011
 21 Supplement 3 p. S433-S434
2 p.
 artikel
79 P.1.e.017 The functional brain correlates of the psychedelic state: an arterial spin labelling study with psilocybin Carhart-Harris, R.
 2011
 21 Supplement 3 p. S313-
1 p.
 artikel
80 P.3.e.002 The neuropsychological effects of group cognitive-behavioural therapy in schizophrenic outpatients treated with second generation antipsychotics: a randomised control trial Tang, T. Tze-Chun
 2011
 21 Supplement 3 p. S513-
1 p.
 artikel
81 P.1.f.003 Action -inhibition: understanding serotonergic and dopaminergic control of the behaviour of gastropods Hodgkinson, S.
 2011
 21 Supplement 3 p. S327-
1 p.
 artikel
82 P.3.004 Family-based association study of glycogen synthase kinase 3 (GSK3)-beta gene polymorphism in schizophrenia Skibinska, M.
 2011
 21 Supplement 3 p. S143-S144
2 p.
 artikel
83 P.3.f.001 Role of ubiquitin proteasome system in schizophrenia Fernandez-Enright, F.
 2011
 21 Supplement 3 p. S523-
1 p.
 artikel
84 P.2.g.003 Efficacy of adjunct quetiapine extendedrelease in major depressive disorder: a pooled analysis of SSRI and SNRI patient subgroups Bauer, M.
 2011
 21 Supplement 3 p. S441-S442
2 p.
 artikel
85 P.1.g.001 Enhancement of cognitive performance by gabapentin in Morris water maze, elevated plus maze and passive avoidance tasks in naive mice Celikyurt, I. Komsuoglu
 2011
 21 Supplement 3 p. S329-
1 p.
 artikel
86 P.1.g.015 Neurocognitive and psychosocial functioning over a 5 year follow-up in first psychotic episodes González-Ortega, I.
 2011
 21 Supplement 3 p. S337-
1 p.
 artikel
87 P.2.g.017 Opioid effects on the symptoms of psychological trauma and depression in burn patients Park, J.E.
 2011
 21 Supplement 3 p. S450-
1 p.
 artikel
88 P.1.g.032 Short -term and long-term memory changes after electroconvulsive treatment Dragasek, J.
 2011
 21 Supplement 3 p. S347-
1 p.
 artikel
89 P.2.h.001 The phospholipase C inhibitor U73122 inhibits the in vitro and in vivo activity of the novel anxiolytic and antidepressant compound BNC210 O'Connor, S.
 2011
 21 Supplement 3 p. S451-S452
2 p.
 artikel
90 P.8.002 Hydrolysis of 1-methyl-5-phenyl-3-acetoxy-7-bromo-1,2-dihydro-3H-1,4-benzodiazepine-2-one with the help of pig liver microsomes Shesterenko, E.A.
 2011
 21 Supplement 3 p. S172-S173
2 p.
 artikel
91 P.4.005 Impairment of synaptic cell adhesion molecule expression in the medial prefrontal cortex in the neurodevelopmental model of schizophrenia Mordalska, P.
 2011
 21 Supplement 3 p. S82-
1 p.
 artikel
92 P.6.009 Influence of olfactory bulbectomy on extinction and drug-seeking behaviour in rats exposed to intravenous cocaine self-administration Filip, M.
 2011
 21 Supplement 3 p. S164-S165
2 p.
 artikel
93 P.2.007 Lipolysaccharide-induced changes in brain stimulation reward: anhedonia or sickness behaviour? Prins, J.
 2011
 21 Supplement 3 p. S39-S40
2 p.
 artikel
94 P.1.026 Low dose nicotine improves 6-OHDA-induced impairment of memory, oxidative stress and food reward in nucleus accumbens Ciobica, A.
 2011
 21 Supplement 3 p. S130-S131
2 p.
 artikel
95 P.6.006 Molecular genetic markers of the duration of therapeutic remission in patients with alcohol dependence Kibitov, A.
 2011
 21 Supplement 3 p. S163-
1 p.
 artikel
96 P.4.015 Reboxetine augments the antipsychotic-like effect of quetiapine and enhances cortical dopamine output and NMDA-induced currents Björkholm, C.
 2011
 21 Supplement 3 p. S90-S91
2 p.
 artikel
97 P.1.033 Serotonin uptake in platelets predicts neural activation in the cingulate cortex Scharinger, C.
 2011
 21 Supplement 3 p. S27-
1 p.
 artikel
98 Psychopathology, coronary heart disease and metabolic syndrome in schizophrenia spectrum patients with deficit versus non-deficit schizophrenia: Findings from the CLAMORS study Arango, Celso
 2011
 21 Supplement 3 p. 867-875
9 p.
 artikel
99 P.8.007 The biotechnological production of potential neuroprotectants: oligo-3-hydroxybutyrates Bonartsev, A.P.
 2011
 21 Supplement 3 p. S175-S176
2 p.
 artikel
100 P.3.012 The influence of hormone replacement therapy on the serotonin-1A receptor binding in postmenopausal women Kranz, G.
 2011
 21 Supplement 3 p. S68-S69
2 p.
 artikel
101 P.1.012 The main proinflammatory cytokines in neuroimmune interactions Kovalenko, L.
 2011
 21 Supplement 3 p. S122-S123
2 p.
 artikel
102 P.1.014 Time-dependent alterations of the endocannabinoid system and synaptic markers following adolescent delta-9-tetrahydrocannabinol (THC) administration in female rats Zamberletti, E.
 2011
 21 Supplement 3 p. S13-S14
2 p.
 artikel
103 S.08.01 Apo-ghrelin receptor (GHS-R1a) is a modulator of dopamine signaling Smith, R.G.
 2011
 21 Supplement 3 p. S198-
1 p.
 artikel
104 S.21.05 Beyond controlling symptoms in first episode – subjective well-being, recovery and remission Naber, D.
 2011
 21 Supplement 3 p. S220-
1 p.
 artikel
105 S.3.01 Biomarkers for anxiety disorders: proteomic and systems biology approaches Turck, C.W.
 2011
 21 Supplement 3 p. S110-S111
2 p.
 artikel
106 S.01.05 Can neuroimaging in schizophrenia predict antipsychotic response Hulshoff Pol, H.E.
 2011
 21 Supplement 3 p. S185-S186
2 p.
 artikel
107 S.05.03 Cognitive-behaviour therapy interventions in PRS: short-term and long-term outcomes Bechdolf, A.
 2011
 21 Supplement 3 p. S192-
1 p.
 artikel
108 S.22.04 Depression and suicide following subthalamic stimulation: basic mechanisms Sharp, T.
 2011
 21 Supplement 3 p. S221-
1 p.
 artikel
109 Second generation antipsychotics (SGAs) for non-psychotic disorders in children and adolescents: A review of the randomized controlled studies Zuddas, Alessandro
 2011
 21 Supplement 3 p. 600-620
21 p.
 artikel
110 S.12.04 Gender differences in brain function associated with cognitive and emotion processing in schizophrenia Mendrek, A.
 2011
 21 Supplement 3 p. S204-
1 p.
 artikel
111 S.18.03 Mitochondria, free radicals and inflammation in mood disorders and functional syndromes Gardner, A.
 2011
 21 Supplement 3 p. S215-
1 p.
 artikel
112 S.3.04 Phenotype of stress response and effects of psychotropic drugs Seredenin, S.
 2011
 21 Supplement 3 p. S113-
1 p.
 artikel
113 S.08.04 Relationship between ghrelin and alcohol craving and intake: recent clinical findings Leggio, L.
 2011
 21 Supplement 3 p. S199-
1 p.
 artikel
114 S.26.01 Structural imaging of development in serotonergic brain systems Jernigan, T.L.
 2011
 21 Supplement 3 p. S227-
1 p.
 artikel
115 S.02.05 What can we learn from the large US Cohort study (STEP-BD) Fagiolini, A.
 2011
 21 Supplement 3 p. S187-
1 p.
 artikel
                             115 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland